Trastuzumab Terminated Phase 2 Trials for Urinary Tract Cancers Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02013765A Study of Herceptin (Trastuzumab) Monotherapy in Patients With Metastatic Urothelial Cancer